Document Detail


Immunohistochemical detection of the BRAF V600E-mutated protein in papillary thyroid carcinoma.
MedLine Citation:
PMID:  22592144     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The V600E mutation of the B-type Raf kinase (BRAF) gene is a common event in papillary thyroid carcinoma (PTC) and seems to play a key role in the development and progression of this disease. We evaluated the expression of the mutated BRAF V600E protein in 144 cases of PTC using a novel mutation-specific antibody. Seventy-six PTCs (52.8%) showed unequivocal diffuse cytoplasmic expression of the mutated BRAF protein, and the T1799A point mutation was confirmed by sequencing analysis in selected cases. No statistical difference in V600E BRAF protein expression was seen between microcarcinomas and macrocarcinomas. Further, no significant correlation of V600E expression with clinicopathologic parameters of aggressiveness such as lymph node metastasis, peritumoral infiltration, or perithyroidal infiltration was found. BRAF V600E protein expression was significantly more common in tumors with tall cell or oncocytic features but was less common in tumors with follicular growth pattern. Diffuse sclerosing, solid and follicular variants did not show the mutated BRAF protein. Immunohistochemical detection of the mutated V600E BRAF protein in PTC may facilitate mutational analysis in the clinical setting. Our data show that the expression of the mutated BRAF V600 protein and thus the corresponding BRAF mutation seems not to be per se a marker of aggressiveness but is already seen in clinically indolent microcarcinomas. Nevertheless, the investigation of BRAF V600E protein expression might be of clinical interest especially in therapy-resistant disease, as new therapeutics inhibiting the mutated protein are clinically available.
Authors:
Oskar Koperek; Christoph Kornauth; David Capper; Anna Sophie Berghoff; Reza Asari; Bruno Niederle; Andreas von Deimling; Peter Birner; Matthias Preusser
Related Documents :
22292044 - Genes involved in sex pheromone discrimination in drosophila melanogaster and their bac...
22370934 - Molecular characterization of the andean blackberry, rubus glaucus, using ssr markers.
22564834 - Substrate spectrum extension of pena in burkholderia thailandensis with a single amino ...
20875064 - Linking the planktonic and benthic habitat: genetic structure of the marine diatom skel...
10781564 - Multiple-locus variable-number tandem repeat analysis reveals genetic relationships wit...
10630184 - Ethnic differences in cancer risk resulting from genetic variation.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of surgical pathology     Volume:  36     ISSN:  1532-0979     ISO Abbreviation:  Am. J. Surg. Pathol.     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-05-17     Completed Date:  2012-07-10     Revised Date:  2012-11-08    
Medline Journal Info:
Nlm Unique ID:  7707904     Medline TA:  Am J Surg Pathol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  844-50     Citation Subset:  IM    
Affiliation:
Clinical Institute of Pathology, Medical University of Vienna, Währinger Gürtel 18-20, Vienna, Austria.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma, Papillary / genetics,  metabolism*,  pathology
Adolescent
Adult
Aged
Aged, 80 and over
Child
DNA Mutational Analysis
DNA, Neoplasm / analysis
Female
Humans
Immunohistochemistry
Male
Middle Aged
Point Mutation
Proto-Oncogene Proteins B-raf / genetics,  metabolism*
Thyroid Gland / metabolism,  pathology,  surgery
Thyroid Neoplasms / genetics,  metabolism*,  pathology
Thyroidectomy
Young Adult
Chemical
Reg. No./Substance:
0/DNA, Neoplasm; EC 2.7.11.1/BRAF protein, human; EC 2.7.11.1/Proto-Oncogene Proteins B-raf
Comments/Corrections
Erratum In:
Am J Surg Pathol. 2012 Oct;36(10):1578

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pa...
Next Document:  Malignant gastrointestinal neuroectodermal tumor: clinicopathologic, immunohistochemical, ultrastruc...